{"database": "lobbying", "table": "lobbying_activities", "rows": [[1424999, "bda760ff-2d08-418c-b59b-c96b5d1ac454", "Q2", "BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC", 292972, "BOEHRINGER INGELHEIM USA CORPORATION", 2013, "second_quarter", "ANI", "Illegal Compounding", "HOUSE OF REPRESENTATIVES,SENATE", null, 730000, 0, 0, "2013-07-22T12:29:46.387000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["1424999"], "units": {}, "query_ms": 17.805400071665645, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}